Pam3CSK4 TFA is a toll-like receptor 1/2 (TLR1/2) agonist with an EC 50 of 0.47 ng/mL for human TLR1/2.
性状
Solid
IC50 & Target[1][2]
TLR1 TLR2
体外研究(In Vitro)
Pam3CSK4 is a TLR1/2 heterodimer recognises triacylated lipopeptides.Pam3CSK4 (1 μg/mL) enhances the antibacterial functions of granulocyte macrophage-colony stimulating factor (GM-CSF) induced neutrophils to Methicillin-resistant Staphylococcus aureus (MRSA). has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Pam3CSK4 (5 mg/kg; i.p.; once a day for 9 days) alters brain, spleen and liver weights in neonatal mice. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Time-mated pregnant C57BL/6 wi
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
参考文献
[1]. Irvine KL, et al. The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6. Vet Res. 2013 Jul 4;44:50.[2]. Chen Y, et al. TLR2 agonist Pam3CSK4 enhances the antibacterial functions of GM-CSF induced neutrophils to methicillin-resistant Staphylococcus aureus. Microb Pathog. 2019 May;130:204-212.
溶解度数据
In Vitro: DMSO : 50 mg/mL (26.99 mM; Need ultrasonic)H2O : 16.67 mg/mL (9.00 mM; Need ultrasonic)配制储备液